TUOXIN
TUOXIN is a high-tech enterprise integrating the R&D, production, and sales of chemical synthesis and biological fermentation of nucleoside pharmaceutical intermediates. They offer nucleoside fermentation technology platforms and biotransformation semi-synthesis technology platforms and products, such as cytosine, 5-fluorocytosine, cytidine, and other pharmaceutical intermediates.
TUOXIN
Social Links:
Industry:
Biotechnology Manufacturing Medical Pharmaceutical
Founded:
2005-02-03
Address:
Xinxiang, Henan, China
Country:
China
Website Url:
http://www.tuoxinchem.com
Total Employee:
101+
Status:
Active
Contact:
0086-373-6351890
Total Funding:
53 M CNY
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Content Delivery Network Mobile Non Scaleable Content Apache Pound Sterling PHP Japanese Yen PHP 7
Similar Organizations
AB Pharma
AB Pharma is a pharmaceutical company that engages in the development and production of innovative drugs.
CStone Pharmaceuticals
CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Taxus Pharma
Taxus Pharma is a pharmaceutical company that specializes in the research, development, production, and sales of taxane anti-tumor drugs.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Stock Details
Investors List
Southwest Securities
Southwest Securities investment in Post-IPO Equity - TUOXIN
CICC Wealth Management
CICC Wealth Management investment in Post-IPO Equity - TUOXIN
Macrolink Group
Macrolink Group investment in Angel Round - TUOXIN
Official Site Inspections
http://www.tuoxinchem.com
- Host name: 120.48.69.135
- IP address: 120.48.69.135
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai
More informations about "TUOXIN"
About-Tuoxin Pharmaceutical Group Co., Ltd. - en.tuoxinchem.com
Tuoxin Pharmaceutical is a Sino-foreign joint venture enterprise that integrates the production and sale of bio-fermented, chemically synthesized nucleoside series of intermediates and raw …See details»
拓新药业集团股份有限公司
拓新药业是集生物发酵、化学合成核苷系列医药中间体及核苷系列原料药生产和销售为一体的中外合资企业，是中国实力较强的核苷和核苷酸类药物研制、生产基地之一。联系电 …See details»
TUOXIN - Crunchbase Company Profile & Funding
TUOXIN is a high-tech enterprise integrating the R&D, production, and sales of chemical synthesis and biological fermentation of nucleoside pharmaceutical …See details»
Tuoxin Pharmaceutical Group Co., Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Tuoxin Pharmaceutical Group Co., Ltd. of Xinxiang, Henan. Get the latest business insights from Dun …See details»
Company Tuoxin Pharmaceutical Group Co.,Ltd.
Jun 30, 2005 Tuoxin Pharmaceutical Group Co.,Ltd.: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Shenzhen ...See details»
Tuoxin Pharmaceutical Group Company Description - Stock Analysis
Apr 28, 2025 Company profile for Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089) with a description, list of executives, contact details and other key facts.See details»
Tuoxin - Overview, News & Similar companies | ZoomInfo.com
Www.tuoxinchem.com. Revenue <$5 Million. Industry Food, Beverages & Tobacco Manufacturing . Recent News & Media. No recent news or media. Overview ; Org Chart ; Who is Tuoxin. …See details»
关于拓新 - 拓新药业 - m.tuoxinchem.com
新乡拓新药业股份有限公司（以下简称公司）是集化学合成、生物发酵核苷（酸）类原料药及医药中间体的研发、生产及销售为一体的高新技术企业，在国内核苷（酸）类原料药及医药中间体 …See details»
Tuoxin Pharmaceutical Group Co., Ltd.
Tuoxin Pharmaceutical is a Sino-foreign joint venture enterprise that integrates the production and sale of bio-fermented, chemically synthesized nucleoside series of intermediates and raw materials for nucleoside series of drugs. It is …See details»
走进拓新-拓新药业集团股份有限公司 - tuoxinchem.com
拓新药业是集生物发酵、化学合成核苷系列医药中间体及核苷系列原料药生产和销售为一体的中外合资企业，是中国实力较强的核苷和核苷酸类药物研制、生产基地之一。联系电话：13937395559See details»
Tuoxin Pharmaceutical - Products, Competitors, Financials, …
Oct 27, 2021 Tuoxin Pharmaceutical is an enterprise focused on the research, production, and sales of plant-based pharmaceuticals and their intermediates. Use the CB Insights Platform to …See details»
Tuoxin Pharmaceutical Group - PharmaSource
Tuoxin Pharmaceutical Group is a Manufacturer/Innovator company operating in the pharmaceutical industry.. TUOXIN GROUP is a SINO-FOREIGN joint venture company …See details»
Xinxiang Tuoxin Biochemical Co., Ltd Company Information Phone …
Xinxiang Tuoxin Biochemical Co.,Ltd has already been a SINO-FOREIGN joint venture company that integrating the innovation research & development, commercial production of the …See details»
关于我们，新乡拓新生化科技有限公司
联系人： 康永、杨娜 电话： 0373-5066207 手机： 13598688336 传真： 0373-5066337 网站： www.tuoxinchem.com 地址： 中国河南新乡高新技术开发区See details»
拓新药业
拓新药业集团股份有限公司是一家高新技术企业，专注于核苷（酸）类原料药及医药中间体的研发、生产和销售。See details»
Xinxiang Tuoxin Biochemical Technology & Science Co., Ltd.
Www.tuoxinchem.com +86 (373) 506-6207 351-1287: Please mention chemBlink for business contacts. Fax +86 (373) 506-6337: [email protected]: Location: China: Business Type: …See details»
投资者关系-拓新药业集团股份有限公司 - tuoxinchem.com
拓新药业是集生物发酵、化学合成核苷系列医药中间体及核苷系列原料药生产和销售为一体的中外合资企业，是中国实力较强的核苷和核苷酸类药物研制、生产基地之一。联系电 …See details»
产业布局-拓新药业集团股份有限公司 - tuoxinchem.com
拓新药业是集生物发酵、化学合成核苷系列医药中间体及核苷系列原料药生产和销售为一体的中外合资企业，是中国实力较强的核苷和核苷酸类药物研制、生产基地之一。联系电 …See details»
新乡拓新药业股份有限公司 年产540吨核苷系列原料药及医药中间 …
新乡拓新药业股份有限公司. 年产 540吨核苷系列原料药及医药中间体 项目 . 概 述 . 1 项目由来. 新乡拓新股份有限公司是集核苷系列医药中间体及 核苷系列原料药 生产和销售为一体的中外合 …See details»
新乡拓新药业股份有限公司年产540吨核苷系列原料药及医药中间 …
《新乡拓新药业股份有限公司年产540吨核苷系列原料药及医药中间体项目》环境影响评价工作已开始进行，根据《中华人民共和国环境影响评价法》和《环境影响评价公众参与暂行办法》（ …See details»